3 results
Approved WMOCompleted
Primary Objectives:1. To evaluate the efficacy of anacetrapib 100 mg for 24 weeks relative to placeboon plasma concentrations of LDL-C (BQ method).2. To evaluate the efficacy of anacetrapib 100 mg for 24 weeks relative to placeboon plasma…
Approved WMORecruiting
Evaluation whether there is 99mTc-IL2 uptake in vulnerable carotid plaques of patients on long-term treatment with statins.
Approved WMORecruiting
To assess the effectiveness and cost-effectiveness of providing an online personalized self-management program as a first-lineintervention to men with lower urinary tract symptoms (LUTS) compared to care as usual (CAU).